ESC 365 - Lp(a) potential for treatment.

ESC Professional Premium Access

Lp(a) potential for treatment.

Session: Frontiers in cardiometabolic disease

Topic: European Society of Cardiology

Speaker: Professor S. Nicholls (Melbourne, AU)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

55 presentations

5 followers

2 more presentations in this session

GLP1 agonists for obesity and diabetes.

Speaker: Professor J. Ako (Sagamihara, JP)

APSC Consensus statement on lipid management.

Speaker: Doctor N. Koh (Singapore, SG)

Access the full session

Frontiers in cardiometabolic disease

Speakers: Professor S. Nicholls, Professor J. Ako, Doctor N. Koh

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources